A

Atea Pharmaceuticals
D

AVIR

3.36000
USD
0.11
(3.38%)
Market Closed
Volume
7,757
EPS
0
Div Yield
-
P/E
-2
Market Cap
283,795,878
OverviewSignalsIdeasNews
Related Instruments
    A
    ABUS
    0.01000
    (0.28%)
    3.64000 USD
    A
    ADAP
    -0.00320
    (-0.54%)
    0.58680 USD
    A
    ASND
    2.160
    (1.74%)
    126.510 USD
    C
    CRNC
    -0.09500
    (-3.02%)
    3.05000 USD
    G
    GERN
    -0.04000
    (-1.08%)
    3.66500 USD
    I
    ICHR
    -1.550
    (-4.87%)
    30.250 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    X
    XENE
    -1.920
    (-4.60%)
    39.850 USD
    More
News

Title: Atea Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).